Evolvence India Life Sciences Fund

Evolvence India Life Sciences Fund was established in 2006 to provide growth capital to companies operating in the Indian healthcare sector. EILSF is sponsored by Evolvence Capital. In addition, its investors include leading institutional investors, family offices, pension funds, and sovereign wealth funds from Europe and the GCC region.

EILSF invests in small to mid-sized pharmaceutical, biopharmaceutical, medical device, contract R&D, and healthcare services businesses which are either located in India or which derive significant competitive advantage from operations located in India.  Examples of investments include providing capital for capacity expansion, development of generic versions of drugs facing patent expiry,  domestic and international acquisitions and up-gradation of existing infrastructure to emerge as ‘partner of choice’ for contract R&D and manufacturing activities.

EILSF’s team of investment professionals has an in depth understanding of the global life sciences sector, operational experience, and a privileged network of contacts in India and other major international markets. The overarching investment strategy of the fund was developed after a thorough analysis of the Indian pharma and healthcare sectors and key global macro trends.

Post-investment, the EILSF team partners with management teams of the portfolio companies helping them recognise and capture untapped value in the business they operate in. The team provides strategic guidance based on proprietary market insight, helps identify opportunities for improving business processes and achieving operational excellence, and assists companies in business development activities overseas.

For more info: lifesciences@evolvence.com